With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.

In theory, CRISPR gene editing could be used to make any modification to the DNA of virtually any living ... The therapy involves editing patients’ hematopoietic stem cells to induce the production of ...

However, comprehending the intricate interplay and regulatory mechanisms between the maternal-fetal genome and PTB, as well as the multi-level molecular signals (transcription, protein, metabolism, ...

YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204 , an investigational ...

Vertex, along with CRISPR Therapeutics, has developed a gene-editing therapy called Casgevy (exagamglogene autotemcel), which is ... a patient’s hematopoietic stem cells are collected and modified in ...

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes referred to as “the next big thing in agriculture.” The important ...

Collins, along with Matthew Lau ’25, developed the affordable CRISPRKit to make CRISPR gene-editing technology accessible to high school students underrepresented in the sciences. The kit was ...

The company's innovative approach to gene editing has garnered significant attention ... has shown rapid engraftment and high levels of fetal hemoglobin (HbF) in early clinical data.

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.